DEL MONTE CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data DEL MONTE CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	4,012	4,086	4,494	4,489	4,202	4,252	4,442	4,321	4,280	4,322
Cost of revenue	3,550	3,754	4,208	4,183	3,951	3,948	4,102	3,970	3,922	3,923
Gross profit	461	332	286	306	251	304	340	351	358	399
Selling, general and administrative	187	173	201	202	196	193	187	187	197	213
Selling and marketing	17.2	12.8	15.2	14.9	14.6	13.6	9.3	10.5	12.7	10.7
Operating income	244	153	38.6	114	76.5	111	156	58.5	196	137
Interest expense	4.1	6.4	23.6	25.4	21.4	20.3	24.4	24.1	18.4	11.2
Other non-operating income	-3.4	-3	-15.7	0.9	-4.5	-9.4	-14.8	-18.3	-17.6	-10.3
Pre-tax income	237	144	0.2	90.7	51.3	81.9	118	16.5	171	131
Income tax	11.8	24.9	16.1	21.4	5	2	20.1	18.1	29.1	37.4
Net income to minority interests	0.5	-1.6	6	2.8	-2.9	-0.1	-0.9	9.8	-0.6	2.8
Net income	225	121	-21.9	66.5	49.2	80	98.6	-11.4	142	90.7
EBITDA	323	233	139	212	172	208	249	143	275	210
EPS, basic	4.37	2.40	-0.45	1.38	1.03	1.68	2.06	-0.24	2.97	1.90
EPS, diluted	4.33	2.39	-0.45	1.37	1.03	1.68	2.06	-0.24	2.96	1.88
Shares, basic (weighted)	51.5	50.2	48.6	48.3	47.6	47.5	47.8	48	47.9	47.8
Shares, diluted (weighted)	52	50.6	48.6	48.4	47.7	47.7	47.9	48	48	48.2
Dividend per share	0.55	0.60	0.60	0.14	0.30	0.50	0.60	0.75	1.00	1.20

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	20.1	25.1	21.3	33.3	16.5	16.1	17.2	33.8	32.6	35.7
Receivables	349	359	378	364	359	343	374	387	393	376
Inventory	493	542	565	552	508	603	669	600	595	582
Other current assets	35.6	20.5	33.3	19.8	34.9	24	23.4	24	24.3	51.6
Total current assets	961	1,020	1,139	1,052	1,012	1,096	1,241	1,144	1,133	1,141
Property, plant and equipment	1,272	1,328	1,392	1,403	1,420	1,416	1,310	1,256	1,192	1,120
Lease right-of-use assets			0	162	171	199	214	214	186	193
Goodwill	261	262	423	424	424	424	423	402	396	390
Intangible assets	3.4	45.9	167	158	150	143	135	33.3	33.2	33.1
Other non-current assets	91.1	49.9	59.7	49	46.9	57.9	70.9	60.7	68.7	74.1
Total assets	2,653	2,767	3,255	3,350	3,263	3,398	3,459	3,184	3,096	3,059
Accounts payable	163	183	331	285	267	320	296	243	228	238
Accrued liabilities	17.2	18.8	55.1	51.1	45.7	45.2	37.3	29.6	30.1	17.3
Short-term debt	0.6	0.6	0.5	0.3	0.2	1.3	1.3	1.4	1.5	1.5
Total current liabilities	369	394	586	563	555	629	607	541	533	529
Long-term debt	232	357	662	587	542	528	547	406	249	176
Lease liabilities			0	103	114	136	147	142	122	126
Other non-current liabilities	50.8	42.4	53.4	70.9	93	72.1	28.5	27.6	26.8	25.9
Total liabilities	837	976	1,486	1,551	1,463	1,525	1,484	1,271	1,089	1,029
Total debt	269	396	725	587	542	529	548	408	250	178
Paid-in capital	550	523	527	531	533	541	548	598	605	607
Retained earnings	1,286	1,275	1,206	1,253	1,271	1,328	1,398	1,341	1,435	1,447
Other comprehensive income	-44.2	-30.6	-41.6	-65.4	-77	-66.9	-41.5	-43.3	-50.4	-38.2
Shareholders' equity	1,792	1,767	1,692	1,719	1,728	1,802	1,905	1,896	1,991	2,016
Minority interests	24.6	23.8	25.8	24.5	21.7	21.7	20.9	16.4	16.3	14
Total equity	1,816	1,791	1,718	1,744	1,750	1,824	1,926	1,913	2,007	2,030
Total liabilities and equity	2,653	2,767	3,255	3,350	3,263	3,398	3,459	3,184	3,096	3,059
Shares outstanding	51.3	48.8	48.4	48	47.4	47.6	47.8	47.6	47.9	47.4

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	226	119	-15.9	69.3	46.3	79.9	97.7	-1.6	142	93.5
Depreciation and amortization	78.5	79.9	101	97.9	95	96.8	92.5	84.8	78.5	72.5
Stock-based compensation	24.9	12.1	11.5	8.4	7.5	7.6	6.9	9.9	6.9	10
Deferred income tax	-8.2	1.6	3.6	5.2	-0.5	-15	2.5	-3.8	3.5	8
Change in receivables	5.8	-16.9	-2.4	22.1	16.1	-13.9	-37.4	-19.3	-9.8	35.1
Change in inventory	-11.8	-49.4	-2.8	8.1	38.7	-105	-72.1	64.7	-1.5	2.5
Change in payables	21.1	27	131	-53.3	-11.7	78.3	-17.8	-64.1	11.2	-18.5
Cash from operations	345	194	247	169	181	129	61.8	178	183	245
Capital expenditures	-147	-139	-151	-122	-150	-98.5	-48.1	-57.7	-51.7	-63.8
Acquisitions	-9	0	-358	0	0
Cash from investing	-143	-134	-495	-52.2	-109	-82.5	-49.1	56.4	20.4	-48.7
Debt issued	622	800	1,103	736	752	703	1,066	591	620	354
Debt repaid	-648	-673	-798	-811	-797	-726	-1,046	-730	-776	-425
Stock issued	12.2	1.6	0.8	1.1	0
Share buybacks	-108	-142	-29.4	-17.9	-20.8	0	0	-11.8	0	-29.8
Dividends paid	-28.2	-30.1	-29	-6.7	-14.3	-23.7	-28.7	-35.9	-47.8	-57.4
Cash from financing	-205	-53.8	242	-109	-85.8	-53.2	-12	-214	-210	-166
Exchange rate effect	-0.7	-1.6	2.4	4	-2.8	6.8	0.4	-4.2	5.8	0.9
Net change in cash	-4.8	5	-3.8	12	-16.8	-0.4	1.1	16.6	-1.2	31.6
Free cash flow	198	55.7	96.1	46.8	30.6	30	13.7	120	131	181
Interest paid	3.2	5.8	19.3	23.2	20.6	19.9	23.5	24.2	20.3	13.4
Income taxes paid	13.9	12.3	17	9.8	9.2	9.5	13.3	14.9	16	18.2

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 25, 2026; growth uses fiscal years. Valuation uses the share price of $27.38 on November 10, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	9.6%	Gross profit / revenue.
Operating margin	2.9%	Operating income / revenue.
EBITDA margin	4.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	2.7%	Pre-tax income / revenue.
Net margin	1.9%	Net income / revenue.
FCF margin	-0.8%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	1.5%	Cash from operations / revenue.
Effective tax rate	28.5%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	4.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.3%	Net income / average total assets.
Return on invested capital (ROIC)	3.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	5.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.2%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.2%	Capital expenditures / revenue.
D&A / revenue	1.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	1.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-0.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	0.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	11.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	5.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	9.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-30.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-4.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	12.4%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-23.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-5.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	4.1%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-36.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-2.7%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	13.0%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-36.5%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-3.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	12.8%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	34.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	58.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	6.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	38.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	136.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	42.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	20.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	26.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	32.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	1.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	1.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	3.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-1.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-4.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-1.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.30x	Current assets / current liabilities.
Quick ratio	0.69x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.03x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.25x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	14.4%	Total debt / total assets.
Liabilities / assets	41.6%	Total liabilities / total assets.
Net debt	$478.5M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.36x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	7.48x	Operating income / interest expense.
Working capital	$809.2M	Current assets - current liabilities.
Goodwill and intangibles / assets	13.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	$1.54B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.26x	Revenue / average total assets.
Fixed asset turnover	3.62x	Revenue / average property, plant and equipment.
Inventory turnover	4.66x	Cost of revenue / average inventory.
Days inventory	78 days	365 x average inventory / cost of revenue.
Receivables turnover	10.7x	Revenue / average receivables.
Days sales outstanding	34 days	365 x average receivables / revenue.
Days payables	51 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	62 days	Days inventory + days sales outstanding - days payables.
FCF conversion	-40.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	152.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.72	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$92.46	Revenue / diluted weighted shares.
FCF per share	-$0.70	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.35	Cash from operations / diluted weighted shares.
Book value per share	$42.65	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$32.76	Tangible book value / shares outstanding.
Cash per share	$0.45	(Cash + short-term investments) / shares outstanding.
Payout ratio	69.8%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.29B	Share price x shares outstanding.
Enterprise value	$1.77B	Market cap + total debt - cash - short-term investments.
P/E	15.9x	Market cap / net income. Only when net income is positive.
P/S	0.29x	Market cap / revenue.
P/B	0.64x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.84x	Market cap / tangible book value, when positive.
P/OCF	20.2x	Market cap / cash from operations, when positive.
EV/Sales	0.40x	Enterprise value / revenue.
EV/EBIT	13.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	8.74x	Enterprise value / EBITDA, when both are positive.
FCF yield	-2.6%	Free cash flow / market cap.
Earnings yield	6.3%	Net income / market cap (the inverse of P/E).
Dividend yield	4.4%	Dividends paid over the period / market cap.
Shareholder yield	7.1%	(Dividends paid + share buybacks) / market cap.

What was DEL MONTE CORP's revenue in fiscal 2025?

DEL MONTE CORP reported revenue of $4.32B for fiscal 2025, 1% higher than the year before.

Was DEL MONTE CORP profitable in fiscal 2025?

Yes. Net income was $90.7M, a net margin of 2.1%.

How much free cash flow did DEL MONTE CORP generate in fiscal 2025?

Cash from operations of $245.1M minus capital expenditures of $63.8M left free cash flow of $181.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to DEL MONTE CORP